All posts tagged "Kangmei Pharmaceutical"
-
613ChinaChina Eases Process for Investors to Seek Redress for Securities Fraud
Administrative penalties or criminal judgments will no longer be preconditions for courts to accept civil compensation cases involving securities fraud.
February 6, 2022 -
515ChinaChinese Court Rules Executives, Auditors Liable for Kangmei Fraud
Kangmei Pharmaceutical, its executives and auditors will be held fully liable for CNY 2.5bn of investor losses in China's first ever class action against corporate fraud.
November 18, 2021 -
280ChinaChinese Court Accepts First Class Action Against Listed Company
The CSRC said the lawsuit will help listed companies and intermediaries to improve their internal governance and standardise market operations.
April 20, 2021 -
858China
CSRC Bans Six Executives for Kangmei Pharma Accounting Fraud
The company and 21 of its employees have also been fined for using false documents and transaction records to inflate cash positions.
May 17, 2020
